JP6857613B2 - タンパク質の安定化 - Google Patents

タンパク質の安定化 Download PDF

Info

Publication number
JP6857613B2
JP6857613B2 JP2017551685A JP2017551685A JP6857613B2 JP 6857613 B2 JP6857613 B2 JP 6857613B2 JP 2017551685 A JP2017551685 A JP 2017551685A JP 2017551685 A JP2017551685 A JP 2017551685A JP 6857613 B2 JP6857613 B2 JP 6857613B2
Authority
JP
Japan
Prior art keywords
protein
preferentially
composition
carbon atoms
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017551685A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018516239A (ja
JP2018516239A5 (enExample
Inventor
ノノ メルヴェイユ
ノノ メルヴェイユ
デカン ニコラ
デカン ニコラ
シモン ドニ
シモン ドニ
ホイスラー オラフ
ホイスラー オラフ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roquette Freres SA
Original Assignee
Roquette Freres SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres SA filed Critical Roquette Freres SA
Publication of JP2018516239A publication Critical patent/JP2018516239A/ja
Publication of JP2018516239A5 publication Critical patent/JP2018516239A5/ja
Application granted granted Critical
Publication of JP6857613B2 publication Critical patent/JP6857613B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01002—Beta-amylase (3.2.1.2)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
JP2017551685A 2015-04-03 2016-03-30 タンパク質の安定化 Active JP6857613B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1552899A FR3034418B1 (fr) 2015-04-03 2015-04-03 Utilisation de combinaisons particulieres de carbohydrates pour stabiliser des proteines, et compositions proteiques contenant de telles combinaisons
FR1552899 2015-04-03
PCT/FR2016/050709 WO2016156734A1 (fr) 2015-04-03 2016-03-30 Stabilisation de proteines

Publications (3)

Publication Number Publication Date
JP2018516239A JP2018516239A (ja) 2018-06-21
JP2018516239A5 JP2018516239A5 (enExample) 2019-03-07
JP6857613B2 true JP6857613B2 (ja) 2021-04-14

Family

ID=53483991

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017551685A Active JP6857613B2 (ja) 2015-04-03 2016-03-30 タンパク質の安定化

Country Status (7)

Country Link
US (1) US10822372B2 (enExample)
EP (1) EP3277702B1 (enExample)
JP (1) JP6857613B2 (enExample)
CN (1) CN107531747A (enExample)
DK (1) DK3277702T3 (enExample)
FR (1) FR3034418B1 (enExample)
WO (1) WO2016156734A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7039308B2 (ja) * 2017-02-08 2022-03-22 三洋化成工業株式会社 細胞培養用担体
CN108424035A (zh) * 2018-04-19 2018-08-21 中原工学院 一种聚合物水泥发泡剂及其发泡混凝土的制备方法
US20220170002A1 (en) * 2019-03-11 2022-06-02 Nagase Chemtex Corporation Amylase composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE229810T1 (de) 1985-07-09 1987-11-05 Quadrant Bioresources Ltd., Soulbury, Leighton Buzzard, Bedfordshire Beschuetzung von proteinen und aehnlichem.
GB9010742D0 (en) * 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
CA2177429A1 (en) * 1995-06-29 1996-12-30 Charles Allen Rodgers Reduced fat cheese-flavored snack filling
US5876992A (en) * 1996-07-03 1999-03-02 Molecular Biology Resources, Inc. Method and formulation for stabilization of enzymes
WO2000062759A1 (en) * 1999-04-16 2000-10-26 Novo Nordisk A/S Dry, mouldable drug formulation
FI20021312L (fi) * 2002-07-03 2004-01-04 Danisco Sweeteners Oy Polyolikoostumusten kiteyttäminen, kiteinen polyolikoostumustuote ja sen käyttö
CN1681392B (zh) * 2002-09-11 2010-06-09 普瑞图斯股份有限公司 具有木聚糖分解活性的家族8酶在焙烤中的应用
EP1574567A1 (en) * 2004-03-11 2005-09-14 Puratos Naamloze Vennootschap Novel xylanases and their use
SI1954308T1 (sl) * 2005-09-16 2011-12-30 Merial Ltd Stabilizatorji za liofilizirana cepiva
EP2627318B1 (en) * 2010-10-12 2017-08-16 Merz Pharma GmbH & Co. KGaA Formulation suitable for stabilizing proteins, which is free of mammalian excipients
RU2470520C1 (ru) * 2011-07-18 2012-12-27 Валентина Андреевна Васькина Способ производства нуги "мандариновой"
ES2574956T3 (es) * 2011-09-26 2016-06-23 Preanalytix Gmbh Estabilización y aislamiento de ácidos nucleicos extracelulares
CN102533689A (zh) * 2011-12-30 2012-07-04 华东师范大学 一种谷氨酰胺转胺酶真空干燥的制备方法
CN103159839B (zh) * 2013-03-28 2014-07-30 云南天保桦生物资源开发有限公司 热稳定保护的α-淀粉酶抑制剂及其用途
WO2015021600A1 (en) * 2013-08-13 2015-02-19 Danisco Us Inc. Beta-amylase and methods of use
CN104099313B (zh) * 2014-07-18 2016-04-06 天津天绿健科技有限公司 一种啤酒液体复配酶

Also Published As

Publication number Publication date
DK3277702T3 (da) 2023-12-04
JP2018516239A (ja) 2018-06-21
US10822372B2 (en) 2020-11-03
CN107531747A (zh) 2018-01-02
US20180118779A1 (en) 2018-05-03
EP3277702A1 (fr) 2018-02-07
FR3034418B1 (fr) 2018-09-28
WO2016156734A1 (fr) 2016-10-06
EP3277702B1 (fr) 2023-09-06
FR3034418A1 (fr) 2016-10-07

Similar Documents

Publication Publication Date Title
RU2640922C1 (ru) Лиофилизированный препарат ботулотоксина
US20110014676A1 (en) Protein stabilization
Cicerone et al. Substantially improved stability
EP3476386A1 (en) Liquid pharmaceutical composition
US11534403B2 (en) Liquid pharmaceutical composition
JP6857613B2 (ja) タンパク質の安定化
CN103041399B (zh) 一种耐热保护剂及其应用
JP7449243B2 (ja) 安定な融合タンパク質製剤
WO2013133702A1 (en) Methods and compositions for stabilizing dried biological materials
TW202535466A (zh) 抗-il-23p19抗體調配物
EP3207936B1 (en) Stable peptide composition
JP5069661B2 (ja) ヒト血液凝固第ｘｉｉｉ因子の安定化された水性液製剤
JPS63230085A (ja) 安定なフラクト−スデヒドロゲナ−ゼ組成物
WO2017114214A1 (zh) 一种组合物及其应用、含有该组合物的稳定剂
KR20230047124A (ko) 조직 플라스미노겐 활성인자 제형
HK40043029A (en) Lyophilized preparation of botulinum toxin
HK1246174B (en) Lyophilized preparation of botulinum toxin
JP2007174978A (ja) Ａｄａｍｔｓ１３の安定化方法
Eriksson Analytical techniques and formulation strategies for the therapeutic protein alkaline phosphatase
Nandhakumar et al. Lyophillization formulation development with novel excipients for Pegylated therapeutic proteins: A case study
HK40014147B (en) Novel stable formulation for fxia antibodies

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190124

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190124

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20191007

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20191029

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200121

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200602

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200806

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20201028

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201125

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210316

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210322

R150 Certificate of patent or registration of utility model

Ref document number: 6857613

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250